Wella Company files for US IPO after returning to profit under KKR ownership
Wella Company has filed for an initial public offering (IPO) in the US. The move comes after the nail and hair care company backed by investment firm KKR returned to profit and increased its annual revenue to US$2.94 billion.
GLP-1 Drug Semaglutide Slows Aging and Extends Lifespan in Mice
An estimated 11% of Americans are currently taking GLP-1 drugs. Because the drugs, known as a treatment for diabetes and obesity, are widely studied, new research is revealing other, unknown, effects on the human body.
EPA Grants Record Biofuel Exemptions, Moves to Shield Corn and Soybean Demand
September 2026, Washington, D.C.: The U.S. Environmental Protection Agency granted 1.76 billion gallons worth of small r…
Inaugural Biocontrol & Biostimulants North Africa 2026 to Convene Industry Leaders in Cairo This September
NewAg International will host the inaugural Biocontrol & Biostimulants North Africa 2026 from September 22-24, 2026, at the Egypt International Convention Centre in Cairo. Following the success of editions in Spain, Brazil, and the USA, this exciting new addition to the Sahara Expo marks the series’ expansion into the dynamic North African region.
进入美国农药市场，并不只有″从零申请美国EPA登记″这一条路
对于农药企业而言，进入美国市场，美国EPA登记往往是一道重要门槛。自主申请美国EPA农药登记，通常涉及数据、试验、数据补偿及审评周期等多方面投入，时间和成本也因此成为许多企业进入北美市场的主要挑战。 但进入美国市场，并不只有″从零申请美国E…
🎥 TRIC Robotics scales to 1,500 strawberry acres with 15-robot fleet
Ag robotics startup TRIC Robotics has moved from half-acre trials in 2021 to treating more than 1,500 acres of commercia…
UfarmX Facilitates $6.8 Million In Agricultural Credit Across West Africa
Nigerian AgriTech startup UfarmX has facilitated more than US$6.8 million in agricultural commerce across Nigeria, Senegal and Liberia, using blockchain-backed credit infrastructure and farmer data to connect more than 17,000 credit-scored smallholder farmers with agricultural inputs and markets.
异噁唑虫酰胺等12种化学物质新增列入农药管理，禁止违规生产经营
世界农化网中文网报道：2026年8月29日，农业农村部办公厅发布关于异噁唑虫酰胺等化学物质特定用途管理认定的通知。
NovaGo raises $30M to advance regenerative spinal cord therapy
Why it matters: Spinal cord injury remains one of the major areas of unmet medical need in neurology. While acute care and rehabilitation can improve outcomes, there are currently no approved regenerative therapies capable of restoring lost neurological function. Damage to the spinal cord can therefore leave patients with permanent motor and sensory impairments.
Human Pancreatic Duct Cells Show Diabetes Therapy Potential
A study by researchers at Harvard Medical School has shown that loss of function in the aldehyde dehydrogenase family 3 member B2 (ALDH3B2) gene can convert human pancreatic duct cells into functional β-like cells that can secrete insulin in response to glucose, and which lowered blood glucose levels when transplanted into diabetic mice. The team, headed by Peng Yi, PhD, an investigator at Joslin Diabetes Center, and assistant professor of medicine at Harvard Medical School, suggests that their results point to ALDH3B2 as a gene that could potentially be targeted in human pancreatic duct cells to replenish β cell mass for diabetes therapy.